A Clinical Trial to Evaluate the Safety of agenT-797 in COVID-19 Participants With ARDS

Clinical trial NCT04582201 · COMPLETED

Trial details

NCT number: NCT04582201
Sponsor: MiNK Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Respiratory Distress Syndrome, Adult

Start date: 2020-09-21
Primary completion: 2023-04-23
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.